38. Buprenorphine for the Management of Opioid Withdrawal1

  1. Iosief Abraha1 and
  2. Cristina Cusi2

Published Online: 13 AUG 2012

DOI: 10.1002/9781118454503.ch38

Alcohol and Drug Misuse

Alcohol and Drug Misuse

How to Cite

Abraha, I. and Cusi, C. (2012) Buprenorphine for the Management of Opioid Withdrawal1, in Alcohol and Drug Misuse, John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781118454503.ch38

Author Information

  1. 1

    Regional Health Authority of Umbria, Perugia, Italy

  2. 2

    Outpatient Services – Neurology, Clinical Institutes of Specialisation, Milan, Italy

Publication History

  1. Published Online: 13 AUG 2012
  2. Published Print: 7 AUG 2012

ISBN Information

Print ISBN: 9780470659694

Online ISBN: 9781118454503



  • buprenorphine in opioid withdrawal management;
  • opioid dependence and managed withdrawal, first step for drug-free;
  • withdrawal suppression with methadone, and methadone dose reduction;
  • relapse to opioid use following detoxification, high/withdrawal rates low;
  • other outcomes, withdrawal signs/symptoms, completion of withdrawal;
  • populations, opioid dependent who underwent managed withdrawal;
  • buprenorphine versus clonidine/lofexidine, resolving with buprenorphine;
  • buprenorphine for withdrawal, higher in post-detoxification;
  • buprenorphine, effectiveness over clonidine/lofexidine in opioid withdrawal


This chapter contains sections titled:

  • Reference